Miquel Nolla-Salas | Fungal Infections and Challenges in Treatment | Best Researcher Award

Posted on by Infectious

Best Researcher Award

Miquel Nolla-Salas
Unió-Consorci-Formació, Spain

Miquel Nolla-Salas
Affiliation Unió-Consorci-Formació
Country Spain
Scopus ID 6701580090
Documents 32
Citations 159
h-index 5
Subject Area Fungal Infections and Challenges in Treatment
Event International Research Awards on Infectious Diseases
ORCID 0000-0002-8765-5506

The Best Researcher Award recognition highlights the scholarly contributions of Miquel Nolla-Salas in the field of infectious diseases, with particular emphasis on fungal infections, candidiasis, intensive care medicine, and treatment challenges. Through research, supervision, clinical investigations, and scientific dissemination, the researcher has contributed to the advancement of evidence-based approaches that support improved understanding of opportunistic fungal diseases and their management in healthcare settings.[1]

Abstract

Miquel Nolla-Salas has developed an academic and clinical research profile focused on infectious diseases, critical care medicine, and fungal infections. His scientific work has addressed the epidemiology, diagnosis, prevention, and treatment of candidiasis and related opportunistic infections among hospitalized and critically ill patients. Through peer-reviewed publications, postgraduate supervision, and collaborative investigations, he has contributed to the generation of clinical evidence supporting therapeutic decision-making and improved patient management. His scholarly record demonstrates sustained engagement with infection control challenges and the advancement of medical knowledge relevant to healthcare professionals, researchers, and clinical institutions worldwide.[1][2]

Keywords

Fungal Infections, Candidiasis, Infectious Diseases, Intensive Care Medicine, Clinical Research, Antifungal Therapy, Epidemiology, Critical Care, Medical Education, Healthcare Outcomes.

Introduction

Research concerning fungal infections remains a significant component of infectious disease management due to increasing healthcare complexity and vulnerable patient populations. Miquel Nolla-Salas has participated in investigations examining infection prevalence, diagnostic methodologies, and therapeutic interventions that seek to reduce morbidity and improve treatment effectiveness in clinical environments.[2]

Research Profile

The researcher’s academic profile reflects interdisciplinary engagement across infectious diseases, intensive care medicine, and fungal pathogen management. His publication portfolio includes studies addressing candidiasis prevalence, therapeutic evaluation, and infection-related outcomes. Academic activities have additionally included postgraduate mentorship and thesis supervision, supporting the development of future researchers and healthcare professionals.[1][3]

Research Contributions

His research contributions have focused on improving understanding of invasive fungal infections, especially among critically ill patients. Investigations have explored disease identification, risk assessment, therapeutic strategies, and evidence-based clinical management. These contributions have supported broader discussions regarding early diagnosis and optimized antifungal interventions within healthcare systems.[2][4]

Publications

The researcher’s publication record consists of peer-reviewed scientific articles indexed within recognized scholarly databases. These publications address clinically relevant topics associated with infectious diseases and fungal treatment challenges. Citation metrics indicate continuing scholarly visibility and engagement within the scientific community.[1]

Research Impact

Research impact can be evaluated through publication output, citation activity, academic mentorship, and contributions to clinical practice discussions. The documented citation record reflects scholarly engagement with his findings. Furthermore, the translation of research knowledge into clinical contexts demonstrates relevance to healthcare improvement and infectious disease management initiatives.[1][5]

Award Suitability

Miquel Nolla-Salas demonstrates several characteristics commonly associated with recipients of research recognition awards. These include a sustained publication record, measurable citation performance, active participation in scholarly research, contributions to postgraduate supervision, and commitment to advancing knowledge related to fungal infections and treatment challenges. Such achievements align with the objectives of the International Research Awards on Infectious Diseases, which recognize impactful and evidence-based scientific contributions.[1][3]

Conclusion

The academic profile of Miquel Nolla-Salas reflects a career dedicated to addressing significant challenges in infectious diseases and fungal infection management. His scholarly activities, publication contributions, mentorship roles, and clinical research involvement collectively support recognition within the international research community. The body of work demonstrates ongoing relevance to healthcare practice, scientific advancement, and future investigations in infectious disease research.[1][4]

References

  1. Elsevier. (n.d.). Scopus author details: Miquel Nolla-Salas, Author ID 6701580090. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6701580090
  2. Miquel Nolla-Salas; Jordi Ibañez-Nolla. Candida in the ICU, Risk Management and Patient Safety.
    https://doi.org/10.3390/microorganisms14061200
  3. ORCID. (n.d.). Research profile of Miquel Nolla-Salas.
    https://orcid.org/0000-0002-8765-5506
  4. International Journal of Infectious Diseases (2024). Multifocal candidiasis can be considered a form of invasive candidiasis in critically non-neutropenic patients.
    https://doi.org/10.1016/j.ijid.2024.107171
  5. International Research Awards on Infectious Diseases. Award recognition and evaluation framework.
    https://infectious-diseases-conferences.pencis.com/

Lata Deso Abo | Development of New Vaccines | Best Researcher Award

Posted on by Infectious

Mr. Lata Deso Abo | Development of New Vaccines | Best Researcher Award

Lecturer and Researcher | Haramaya University, Haramaya Institute of Technology | Ethiopia

Lata Deso Abo is a Lecturer and Researcher in the Department of Chemical Engineering at Haramaya Institute of Technology, Haramaya University, Ethiopia. He earned his Bachelor of Science degree in Chemical Engineering/Process Engineering from Haramaya University in 2017, followed by a Master of Science in Chemical Engineering with a specialization in Bioenergy Engineering from Addis Ababa Science and Technology University in 2021. His research focuses on sustainable technologies, bioenergy, waste valorization, green innovations, and advanced water treatment, with a particular emphasis on bioethanol production, biomass utilization, and the mitigation of industrial fouling in heat transfer systems. Lata has published extensively in reputable journals including Thermal Science Engineering Progress, Environmental Quality Management, Fuel, Chemosphere, and Results in Engineering, contributing studies on heat exchanger fouling, bioethanol optimization through artificial neural networks, biowaste valorization, and the development of eco-friendly biopesticides. His work has also been presented at international conferences such as EPACT-2022 and the AIP Conference Proceedings. In recognition of his scholarly contributions, he has received multiple awards and certificates for teaching performance, research excellence, and editorial reviewing roles in journals like Results in Engineering, Biomass and Bioenergy, and Journal of Environmental Management. Proficient in English and Amharic, and skilled in computational and chemical engineering tools including Aspen Plus, SuperPro Designer, MATLAB, CHEMCAD, and R programming, Lata Deso Abo combines research, teaching, and innovation to advance chemical engineering knowledge and sustainable solutions, making him a distinguished contributor to both academia and applied engineering research. He has 38 citations from 2 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Chozhavendhan, S., Karthigadevi, G., Bharathiraja, B., Kumar, R. P., Abo, L. D., … (2023). Current and prognostic overview on the strategic exploitation of anaerobic digestion and digestate.

2. Jayakumar, M., Hamda, A. S., Abo, L. D., Daba, B. J., Prabhu, S. V., Rangaraju, M., … (2023). Comprehensive review on lignocellulosic biomass derived biochar production, characterization, utilization and applications.

3. Jayakumar, M., Gebeyehu, K. B., Abo, L. D., Tadesse, A. W., Vivekanandan, B., … (2023). A comprehensive outlook on topical processing methods for biofuel production and its thermal applications.

4. Areti, H. A., Muleta, M. D., Abo, L. D., Hamda, A. S., Adugna, A. A., Edae, I. T., Daba, B. J., … (2024). Innovative uses of agricultural by-products in the food and beverage sector.

5. Gari, M. T., Asfaw, B. T., Arumugasamy, S. K., Abo, L. D., … (Year). Natural resources-based activated carbon synthesis.

Yi HSin Wang | Antibiotic | Best Researcher Award

Posted on by Infectious

Yi HSin Wang | Antibiotic | Best Researcher Award

Assist Prof Dr. Yi HSin Wang , Chung Shan Medical University, Taiwan.

Assist Prof Dr. Yi Hsin Wang is a dedicated researcher specializing in antibiotic discovery and development. With a strong academic foundation in microbiology and pharmacology, she has contributed significantly to the understanding of antibiotic resistance mechanisms and the identification of novel antimicrobial agents. Her work focuses on developing innovative strategies to combat bacterial infections, making a profound impact on public health. Yi Hsin has published numerous articles in peer-reviewed journals and has presented her research at international conferences, showcasing her commitment to advancing the field of antibiotic research. Her dedication to scientific excellence and her contributions to antibiotic development make her a deserving candidate for the Best Researcher Award.

Profile:

Scopus  Profile

Education

Assist Prof Dr. Yi-Hsin Wang pursued his academic journey at Chung Shan Medical University, beginning with a Bachelor of Science degree in Medical Applied Chemistry from 2008 to 2012. He then advanced to the Institute of Medicine at the same university, completing a Master of Science degree from 2012 to 2014 under the guidance of Professors Jinghua Tsai Chang and Shiang-Suo Huang. Building upon his research foundation, Yi-Hsin continued his studies in the Institute of Medicine, where he earned his Ph.D. from 2014 to 2018, with Professors Jinghua Tsai Chang and Shiang-Suo Huang as his advisors once again.

 

Experience 

Assist Prof Dr. Yi-Hsin Wang currently holds the position of Assistant Professor in the Department of Physiology at Chung Shan Medical University’s School of Medicine (2022.08–present). Previously, Wang served as a Postdoctoral Researcher in the Department of Pharmacology at China Shan Medical University’s School of Medicine (2019.08–2022.07) and in the Graduate Institute of Acupuncture Science at China Medical University (2018.09–2019.07), with a strong focus on physiology, pharmacology, and acupuncture science throughout their academic and research career.

 

Skills

Assist Prof Dr. Yi-Hsin Wang possesses a range of experimental skills, including expertise in creating animal models for myocardial infarction and ischemic stroke. Additionally, Wang is proficient in Western blotting, gelatin zymography, and immunohistochemistry, each essential for analyzing protein expression, enzyme activity, and tissue-specific antigen localization.

 

Awards

Assist Prof Dr. Yi-Hsin Wang has received notable awards for contributions to biomedical sciences, including the Young Scientist Travel Award at the 9th FAOPS Congress (2019) in Japan and 2nd place in the Poster Award at the 33rd Joint Annual Conference of Biomedical Sciences (2018) in Taiwan.

 

Research Skills

Assist Prof Dr. Yi-Hsin Wang research expertise encompasses a diverse range of fields, including cardiology, with a focus on cardioprotection, and extends to neuroscience, particularly in the area of neuroprotection. His work also addresses the mechanisms underlying ischemia/reperfusion injury, contributing to a deeper understanding of both brain and cardiovascular physiology.

Top Note Publications

Title: Dunaliella salina Alga Protects against Myocardial Ischemia/Reperfusion Injury by Attenuating TLR4 Signaling

Authors: Tsai, C.-F., Lin, H.-W., Liao, J.-M., … Wang, M., Huang, S.-S.
Year: 2023
Citations: 4

Title: Lumbrokinase Regulates Endoplasmic Reticulum Stress to Improve Neurological Deficits in Ischemic Stroke

Authors: Wang, Y.-H., Liao, J.-M., Chen, K.-M., … Tsai, C.-F., Huang, S.-S.
Year: 2022
Citations: 5

Title: Activation of Peripheral TRPM8 Mitigates Ischemic Stroke by Topically Applied Menthol

Authors: Huang, S.-S., Su, H.-H., Chien, S.-Y., … Lee, H.-H., Chen, Y.-H.
Year: 2022
Citations: 14

Title: In Situ Slow-Release Recombinant Growth Differentiation Factor 11 Exhibits Therapeutic Efficacy in Ischemic Stroke

Authors: Su, H.-H., Yen, J.-C., Liao, J.-M., … Chen, Y.-H., Huang, S.-S.
Year: 2021
Citations: 5

Title: Paeonol Protects Against Myocardial Ischemia/Reperfusion-Induced Injury by Mediating Apoptosis and Autophagy Crosstalk

Authors: Tsai, C.-F., Su, H.-H., Chen, K., … Wang, Y.-H., Huang, S.-S.
Year: 2021
Citations: 27